Emerging data also suggest functional benefits in obesity-related conditions, such as improved physical function in patients with knee osteoarthritis
Physicians appreciate the dual benefit of these drugs in managing both conditions, which is essential given the rising incidence of diabetes in India
Westerfield said that while utilization has been below the states projections, such treatment decisions are up to patients and their doctors
The correct term is triple agonist
A Simple GLP-1 Meal Plan You Can Actually Stick With / 9 Easy High-Protein Meals for Real Life One of the biggest things I hear from clients taking a GLP-1 medication is: "I know I need to eat more protein...I just don't know what to make." If that sounds familiar, you're not alone and this is for you

Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events including death, heart attack, or stroke in adults with obesity and heart disease a claim only Wegovy can make Since launching in January 2026, Wegovy pill has reached 3 million prescriptions * Medicare GLP-1 Bridge participation now expands patient access to authentic, FDA-approved Wegovy , including the Wegovy pill PLAINSBORO, N.J., July 1, 2026 /PRNewswire/ -- Starting today FDA-approved Wegovy (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity